Erdafitinib Monotherapy or in Combination With Cetrelimab in Muscle-invasive Bladder Cancer Patients With Fibroblast Growth Factor Receptor (FGFR ) Gene Alterations
Clinical trial NCT06511648 · RECRUITING
Trial details
- NCT number
- NCT06511648
- Sponsor
- Spanish Oncology Genito-Urinary Group
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-07
- Primary completion
- 2026-07-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.